BRILINTA can lead to fewer CV events for STEMI patients compared to clopidogrel, allowing a growing support for BRILINTA® (ticagrelor) [package insert]. Find out about the BRILINTA® (ticagrelor) mechanism of action. BRILINTA is the first-and-only ;(3) BRILINTA® (ticagrelor) [package insert]. Patient Information Leaflet. Package leaflet: Information for the user. Brilique 90 mg film-coated tablets ticagrelor. Read all of this leaflet carefully before you start .

Author: Tektilar Grojas
Country: Rwanda
Language: English (Spanish)
Genre: Literature
Published (Last): 10 October 2016
Pages: 403
PDF File Size: 11.74 Mb
ePub File Size: 16.5 Mb
ISBN: 900-5-19553-132-8
Downloads: 19439
Price: Free* [*Free Regsitration Required]
Uploader: Dokree

You may report side effects related to AstraZeneca products by clicking here. People who are treated with a stent, and stop taking BRILINTA too soon, have a higher risk of getting a blood clot in the stent, having a heart attack, or dying.


The benefit for patients who undergo primary percutaneous coronary intervention is unknown. Instances of serious bleeding, such as internal bleeding, may require blood transfusions or surgery. Tell insfrt doctor if you take other medicines that contain aspirin. Administer 90 mg twice daily during the first year after an ACS event.


Call your doctor if you have new or unexpected shortness of breath or any side effect that bothers you or that does not go away. Bradyarrhythmias including AV block have been reported in the post-marketing setting. I recently had a heart attack, but I am not a victim.

BRILINTA® (ticagrelor) tablets | Antiplatelet & Heart Attack Treatment

Plavix is indicated to reduce the rate of myocardial infarction and stroke For in hrilinta with acute ST-elevation myocardial infarction STEMI who are to be managed medically. Strong inducers substantially reduce ticagrelor exposure and so decrease the efficacy of ticagrelor As with other oral P2Y 12 inhibitors, co-administration of opioid agonists delay and reduce the absorption of ticagrelor. Strong inhibitors substantially increase ticagrelor exposure and so increase the risk of adverse events.

These can be fatal.

Do not take new medicines that contain aspirin. Plavix has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re pacmage, or stroke. Tell your doctor about all the medicines you take, including prescription and over-the-counter pavkage, vitamins, and herbal supplements. BRILINTA is used with aspirin to lower your chance of having another serious problem with your heart or blood vessels such as heart attack, stroke, or blood clots in your stent if you received one.


Plavix has been shown to decrease the rate of a combined endpoint of cardiovascular death, myocardial infarction MIor stroke as well as the rate of a combined endpoint of cardiovascular death, MI, stroke, brilijta refractory ischemia. Plavix is a registered trademark of sanofi-aventis. For at least the first 12 months following ACS, it is superior to clopidogrel.

Your doctor can decide what treatment is needed.

Evolving Treatment Paradigm in ACS | BRILINTA® (ticagrelor) tablets

After one year administer 60 mg twice daily. Bleeding will also take longer than usual to stop.

You may report side effects related to AstraZeneca products by clicking here. Plavix should be administered in conjunction with aspirin.

The optimal duration of Plavix therapy is unknown. For complete information on changes to the Plavix PI, go to www. Subject to eligibility rules ; restrictions apply.

Previous post: